Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 870

Results For "GE"

9973 News Found

Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer
Biotech | February 15, 2022

Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer

These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium


Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations
People | February 15, 2022

Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations

She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry


Avion Pharmaceuticals announces USFDA approval of DHIVY
Drug Approval | February 15, 2022

Avion Pharmaceuticals announces USFDA approval of DHIVY

Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing


Launches and margin sustainability hold key for Glenmark: ICICI Direct
News | February 15, 2022

Launches and margin sustainability hold key for Glenmark: ICICI Direct

Key takeaways of Q3FY22 quarter & conference call highlights


India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
Healthcare | February 15, 2022

India’s tech-enabled vaccination drive applauded at India-Africa Health Summit

It will open new frontier for south-to-south collaboration and innovation transfer


PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients
Healthcare | February 15, 2022

PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients

The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country


Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit
Medical Device | February 14, 2022

Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit

The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes


Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Drug Approval | February 14, 2022

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data


WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19
Drug Approval | February 14, 2022

WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19

The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification


Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
News | February 14, 2022

Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered